Expression of AKR1C3 and CNN3 As Markers for Detection of Lymph Node Metastases in Colorectal Cancer
Total Page:16
File Type:pdf, Size:1020Kb
Clin Exp Med DOI 10.1007/s10238-014-0298-1 ORIGINAL ARTICLE Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer Chiaki Nakarai • Kayo Osawa • Minami Akiyama • Nagahide Matsubara • Hiroki Ikeuchi • Tomoki Yamano • Seiichi Hirota • Naohiro Tomita • Makoto Usami • Yoshiaki Kido Received: 17 February 2014 / Accepted: 10 May 2014 Ó The Author(s) 2014. This article is published with open access at Springerlink.com Abstract The aim of the study was to identify a set of respectively). The expression of CNN3 was significantly discriminating genes that could be used for the prediction of different between the Dukes’ stage C and B or control groups Lymph node (LN) metastasis in human colorectal cancer (p \ 0.001 and p \ 0.01, respectively). There were signifi- (CRC), and for this, we compared the whole genome profiles cant correlations between the expression levels of AKR1C3 of two CRC cell lines (the primary cell line SW480 and its and CNN3. AKR1C3 and CNN3 expressions are more accu- LN metastatic variant, SW620) and identified eight genes rate and suitable markers for the diagnosis of LN metastasis [S100 calcium-binding protein P; aldo–keto reductase fam- than the other six genes examined in this study. ily 1(AKR1), member B1 (aldose reductase; AKR1B1); AKR1, member C3 (AKR1C3); calponin 3, acidic; metas- Keywords AKR1C3 Á CNN3 Á Lymph node metastasis Á tasis associated in colon cancer 1; hemoglobin, epsilon 1; Colorectal cancer Á Real-time quantitative PCR trefoil factor 3; and FGGY carbohydrate kinase domain containing]. These genes were examined by quantitative Abbreviations RT-PCR in tissues and LNs in 14 CRC patients and 11 LN Lymph node control patients. The level of AKR1C3 mRNA expression CRC Colorectal cancer was significantly different between the Dukes’ stage A, B, UC Ulcerative colitis and C groups and the control group (p \ 0.05, p \ 0.001, CEA Carcinoembryonic antigen and p \ 0.001) and was also significantly different between CXCL10 CXC chemokine ligand 10 Dukes’ stage C and A or B groups (p \ 0.05 and p \ 0.001, ELF3 E74-like factor 3 S100P S100 calcium-binding protein P AKR1 Aldo–keto reductase family 1 & C. Nakarai Á K. Osawa ( ) Á M. Akiyama Á M. Usami Á AKR1B1 AKR1, member B1 Y. Kido Department of Biophysics, Kobe University Graduate School AKR1C3 AKR1, member C3 of Health Sciences, 7-10-2, Tomogaoka, Suma-ku, CNN3 Calponin 3, acidic Kobe 654-0142, Japan MACC1 Metastasis associated in colon cancer 1 e-mail: [email protected] HBE1 Hemoglobin, epsilon 1 N. Matsubara Á H. Ikeuchi Á T. Yamano Á N. Tomita TFF3 Trefoil factor 3 Department of Surgery, Hyogo College of Medicine, FGGY FGGY carbohydrate kinase domain containing Nishinomiya, Japan HES Hematoxylin–eosin staining S. Hirota Department of Surgical Pathology, Hyogo College of Medicine, Nishinomiya, Japan Background Y. Kido Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Lymph node (LN) evaluation is an important factor for Kobe, Japan determining prognosis in colorectal cancer (CRC). LN 123 Clin Exp Med metastases cause recurrence of CRC and are related to the FGGY kinase family that acts as a phosphotransferase prognosis and survival [1]. Carcinoembryonic antigen [16]. In this study, we investigated whether these genes (CEA) was first described as a gastrointestinal oncofetal could be used as biomarkers for detecting LN metastases of antigen and is now known to be overexpressed in most CRC by qRT-PCR. carcinomas [2]. CEA is generally used for the detection of LN metastases in CRC [3, 4]. Detection of cytokeratin-20 by RT-PCR in peritumoral, histopathologic, tumor-free Materials and methods LNs is an independent prognostic factor for overall sur- vival in CRC [5]. A biomarker for identifying patients at Microarray analyses high risk of metastasis could have extensively clinical applications. Recent evidence indicates that CXC Chemo- A total of 54,359 genes in two isogenic CRC cell lines (the primary cell line SW480 and its LN metastatic variant, kine Ligand 10 (CXCL10), an interferon-inducible protein, TM is downregulated in recurrent CRC. Detection of CXCL10 SW620) were analyzed using a CodeLink Human as a prognostic marker for advanced stage CRC patients Whole Genome Bioarray (Applied Microarrays, Inc. may help predict clinical outcomes [6]. Our recent study Tempe, AZ, USA). We entrusted microarray analyses to suggests that the expression of the E74-like factor 3 (ELF3) Filgen, Inc. (Nagoya, Japan). The procedure was identical gene in LNs signals the possibility of metastases and that to that of a previous study [17]. Thirty-five genes with a ELF3 may be more suitable than CEA as a gene marker for fivefold increase in the intensity ratio in SW620 cells the detection of LN metastases from CRC [7]. compared with SW480 were arbitrarily defined as being In the present study, we compared the whole genome overexpressed in SW620 cells (data not shown). Of the 35 profiles of two isogenic CRC cell lines (the primary cell genes that were overexpressed, we selected eight genes line SW480 and its LN metastatic variant, SW620) to (S100P, AKR1C3, CNN3, AKR1B1, MACC1, HBE1, TFF3, identify a set of discriminating genes that could be used for and FGGY) that were extremely overexpressed and were the prediction of metastasis in human CRC. A total of unlikely to be related to inflammation in Table 1. 54,359 genes in SW480 and SW620 cells were analyzed using the Whole Genome Bioarray. As a result, we iden- Patients tified 8 genes that had a fivefold increase in the intensity ratio in SW620 cells as compared with SW480 cells and Twenty-seven tissue specimens (14 tumor specimens and examined by quantitative RT-PCR (qRT-PCR) in tissues 13 non-tumor specimens) and 125 LNs were dissected from and LNs in 14 CRC patients and 11 control patients. The 14 patients with CRC. Non-tumor specimens were located genes selected for examination were S100 calcium-binding far from primary cancer and confirmed not including tumor protein P (S100P); aldo–keto reductase family 1 (AKR1), cells pathologically. Eleven inflammatory tissue specimens member B1 (aldose reductase; AKR1B1); AKR1, member C3 (AKR1C3); calponin 3, acidic (CNN3); metastasis Table 1 Genes upregulated in SW620 cells compared with SW480 cells associated in colon cancer 1 (MACC1); hemoglobin, epsi- lon 1 (HBE1); trefoil factor 3 (intestinal; TFF3); and Accession Gene Gene name Intensity FGGY carbohydrate kinase domain containing (FGGY). number symbol ratio S100P is known to regulate the cellular processes, such as NM_005980 S100P S100 calcium-binding 48.41 cell cycle progression and differentiation [8, 9]. The pro- protein P tein encoded by AKR1B1 catalyzes the reduction of a NM_003739 AKR1C3 Aldo–keto reductase family 1, 18.19 number of aldehydes, including the aldehyde form of member C3 (3-alpha hydroxysteroid glucose, and the protein encoded by AKR1C3 catalyzes the dehydrogenase, type II) conversion of aldehydes and ketones [10, 11]. The protein NM_001839 CNN3 Calponin 3, acidic calmodulin- 16.39 encoded by CNN3 regulates actin cytoskeleton rearrange- binding troponin-like protein ment, which is needed for the plasma trophoblast mem- NM_001628 AKR1B1 Aldo–keto reductase family 1, 15.24 branes to become fusion competent [12]. MACC1 is more member B1 (aldose frequently expressed in advanced CRC [13]. HBE1 is reductase) normally expressed in adult hemoglobin and the leading NM_182762 MACC1 Metastasis associated in colon 11.29 known cause of a b-thalassemia with gene mutation in cancer 1 Southeast Asia [14]. TFF3 is expressed in goblet cells in NM_005330 HBE1 Hemoglobin, epsilon 1 9.79 the intestines and the colon, and overexpression of TFF3 NM_003226 TFF3 Trefoil factor 3 (intestinal) 5.90 after chemoradiotherapy for rectal cancer is associated with NM_018291 FGGY FGGY carbohydrate kinase 5.02 domain containing a higher risk of relapse [15]. FGGY encodes a member of 123 Clin Exp Med Table 2 Clinical and pathological characteristics of patients with Tissue preparation/RNA extraction and cDNA colorectal cancer synthesis Case Dukes’ Histological Tissue preparation, RNA extraction, and cDNA synthesis Locationa stage Histologyb Depth LN metastasis EXc performed in the same way as described in the previous 1 R A tub1 sm – – report [7]. Each RNA from the tissues and LNs was stan- 2 R A tub1 mp – – dardized equal concentration. 3 R B tub1 ss – – 4 D B tub2 ss – – Real-time qRT-PCR 5 A B por1 ss – – 6 A B tub1 ss – – One microliter of cDNA was used as the template in the 7 A B por1 ss – – reaction mixture for real-time qRT-PCR. For determination 8 S B tub2 ss – – of specific gene expression, each primer was designed with 9 A B tub2 ss – – Perfect real-time primer (Takara, Ohtsu, Japan). The 10 A B muc se – ? primers for S100P (GenBank Acc. No. NM_005980), 11 D C por ss ??AKR1C3 (GenBank Acc. No. NM_003739), CNN3 (Gen- 12 D C tub2 ss ? – Bank Acc. No. NM_001839), AKR1B1 (GenBank Acc. No. 13 Rb C tub2 mp ? – NM_001628), MACC1 (GenBank Acc. No. NM_182762), 14 R C tub2 ss ??HBE1 (GenBank Acc. No. NM_005330), TFF3 (GenBank Acc. No. NM_003226), FGGY (GenBank Acc. No. a D descending colon, A ascending colon, R rectum, Rb rectum below NM_018291), and b-actin (ACTB; GenBank Acc. No. peritoneal reflection, S sigmoid colon, T transverse colon NM_001101) are listed in Tables 1 and 3. The parameter b tub1 well-differentiated tubular adenocarcinoma, tub2 moderately differentiated tubular adenocarcinoma, por1 poorly differentiated threshold cycle (Ct) was used as the cycle number to detect solid adenocarcinoma, muc mucinous adenocarcinoma, sm submu- the fluorescence increasing. The housekeeping gene ACTB cosa, mp muscularis propria, ss subserosa, se serosa-exposed was used to calculate the relative level of expression for c EX extramural cancer deposits without lymph node structure each gene and data normalization to correct RNA quality and quantity using the 2-DDCt method.